Sudan
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 7.46 (6.06 - 9.23) | 2015 | Modelled | WHO |
| 5.3 (4.20 - 6.20) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 9.76 (9.03 - 10.54) | 2013 | Modelled | Schweitzer et al, 2015 |
| 4.57 (4.06 - 5.11) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 5.15 (4.58 - 5.75) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.28 (4.70 - 5.91) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.39 (4.82 - 6.02) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.53 (4.90 - 6.18) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.72 (5.07 - 6.38) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.95 (5.28 - 6.63) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.2 (5.51 - 6.91) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.45 (5.71 - 7.19) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.66 (5.87 - 7.46) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.87 (6.06 - 7.71) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.12 (6.25 - 8.01) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.38 (6.46 - 8.28) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.61 (6.62 - 8.61) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.78 (6.72 - 8.86) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.93 (6.84 - 9.02) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.1 (6.98 - 9.23) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.27 (7.14 - 9.42) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.43 (7.26 - 9.61) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.56 (7.36 - 9.80) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.69 (7.48 - 9.92) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.84 (7.62 - 10.08) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.01 (7.79 - 10.25) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.17 (7.94 - 10.42) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.31 (7.99 - 10.62) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.43 (8.10 - 10.73) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.55 (8.20 - 10.91) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.66 (8.27 - 11.08) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.77 (8.35 - 11.26) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.87 (8.38 - 11.46) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.95 (4.41 - 5.51) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.86 (1.95 - 4.02) | 2015 | Modelled | WHO |
| 1.19 (0.94 - 1.51) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1.4 (1.10 - 1.77) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.61 (1.26 - 1.99) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.73 (1.35 - 2.17) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.76 (1.36 - 2.19) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.79 (1.38 - 2.25) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.86 (1.44 - 2.35) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.97 (1.53 - 2.48) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.12 (1.66 - 2.64) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.29 (1.80 - 2.84) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.48 (1.94 - 3.08) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.71 (2.12 - 3.36) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3 (2.34 - 3.72) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.35 (2.59 - 4.15) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 3.73 (2.88 - 4.65) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.16 (3.14 - 5.21) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.73 (3.60 - 5.91) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.46 (4.12 - 6.82) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.22 (4.70 - 7.74) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.87 (5.18 - 8.55) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.28 (5.55 - 9.09) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.51 (5.79 - 9.30) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.7 (5.95 - 9.45) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.87 (6.09 - 9.68) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.01 (6.20 - 9.87) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.12 (6.26 - 10.07) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.22 (6.35 - 10.19) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.32 (6.40 - 10.32) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.41 (6.46 - 10.49) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.5 (6.45 - 10.64) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.57 (6.45 - 10.80) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,084,000 (1,665,000 - 1,472,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 1,863,460 (1,655,830 - 2,084,030) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1,915,860 (1,703,460 - 2,137,570) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,953,100 (1,735,570 - 2,185,570) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,962,440 (1,747,940 - 2,197,970) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,956,500 (1,747,970 - 2,183,380) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,958,750 (1,740,480 - 2,191,850) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,976,570 (1,755,110 - 2,206,990) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,014,350 (1,788,000 - 2,247,550) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,057,430 (1,826,950 - 2,296,240) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,098,110 (1,853,950 - 2,344,140) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,127,990 (1,874,380 - 2,387,580) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,159,100 (1,899,950 - 2,419,720) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,195,370 (1,928,600 - 2,464,500) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,223,720 (1,942,350 - 2,501,200) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,240,340 (1,946,490 - 2,532,830) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,238,780 (1,934,640 - 2,547,570) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,230,620 (1,923,860 - 2,537,420) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,230,890 (1,920,860 - 2,541,260) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,239,020 (1,930,020 - 2,551,070) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,245,410 (1,931,110 - 2,564,790) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,234,150 (1,919,590 - 2,562,560) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,213,590 (1,907,450 - 2,528,060) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,196,830 (1,894,270 - 2,508,960) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,179,960 (1,879,730 - 2,478,180) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,154,670 (1,861,530 - 2,452,570) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,125,910 (1,826,120 - 2,427,380) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,100,340 (1,803,700 - 2,393,380) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,065,990 (1,775,010 - 2,362,570) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,022,090 (1,730,520 - 2,319,580) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,969,220 (1,680,820 - 2,274,710) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,908,330 (1,619,690 - 2,220,830) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 4.28 (2.43 - 7.39) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 12.49 (5.27 - 27.83) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.36 (5.19 - 27.19) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.17 (5.10 - 26.75) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.94 (5.04 - 26.06) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.74 (4.97 - 25.60) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.52 (4.91 - 25.14) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.99 (4.63 - 23.98) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.27 (4.75 - 24.53) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.33 (4.38 - 22.45) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.68 (4.47 - 23.12) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.98 (4.31 - 21.17) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.4 (4.15 - 19.39) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.84 (3.78 - 14.79) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.64 (3.98 - 17.43) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.9 (3.57 - 12.47) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.67 (3.43 - 11.80) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.23 (3.66 - 13.32) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.49 (3.39 - 11.49) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.34 (3.33 - 11.16) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.05 (3.25 - 10.48) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.19 (3.26 - 10.77) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.86 (3.14 - 10.21) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.08 (2.82 - 8.93) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.34 (2.95 - 9.31) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.61 (3.06 - 9.70) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.81 (2.68 - 8.54) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.58 (2.56 - 7.96) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.35 (2.47 - 7.44) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.46 (2.48 - 7.72) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.28 (2.43 - 7.39) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,687 | 2016 | Modelled | WHO |
| 2,523 (1,065 - 5,622) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,601 (1,092 - 5,723) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,659 (1,114 - 5,843) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,696 (1,137 - 5,884) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,728 (1,155 - 5,948) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,745 (1,171 - 5,988) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,774 (1,168 - 6,053) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,769 (1,160 - 5,992) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,761 (1,163 - 6,010) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,748 (1,165 - 5,971) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,720 (1,174 - 5,769) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,615 (1,153 - 5,393) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,443 (1,127 - 4,931) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,129 (1,077 - 3,921) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,260 (1,088 - 4,259) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,060 (1,058 - 3,643) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,079 (1,075 - 3,758) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,052 (1,071 - 3,633) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,053 (1,078 - 3,615) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,046 (1,077 - 3,562) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,037 (1,094 - 3,527) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,008 (1,075 - 3,499) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,962 (1,071 - 3,391) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,906 (1,052 - 3,324) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,852 (1,030 - 3,255) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,796 (1,000 - 3,191) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,760 (982 - 3,054) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,753 (975 - 3,034) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,743 (988 - 2,982) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,746 (990 - 3,014) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,746 (990 - 3,014) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 93 | 2019 | Survey/reported | WHO/UNICEF |
| 90 | 2020 | Survey/reported | WHO/UNICEF |
| 84 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.62 (1.31 - 2.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.31 - 2.02) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.30 - 2.03) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.30 - 2.01) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.62 (1.30 - 2.02) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.63 (1.31 - 2.02) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.64 (1.31 - 2.05) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.65 (1.33 - 2.07) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.67 (1.34 - 2.09) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.69 (1.35 - 2.12) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.7 (1.36 - 2.12) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.71 (1.38 - 2.12) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.73 (1.40 - 2.14) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.74 (1.41 - 2.16) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.76 (1.42 - 2.18) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.77 (1.43 - 2.19) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.79 (1.44 - 2.22) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.8 (1.45 - 2.23) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.81 (1.46 - 2.25) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.83 (1.48 - 2.27) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.85 (1.50 - 2.30) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.87 (1.51 - 2.33) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.89 (1.53 - 2.35) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.91 (1.54 - 2.39) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.93 (1.55 - 2.42) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.95 (1.57 - 2.42) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.97 (1.59 - 2.44) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.99 (1.61 - 2.46) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.01 (1.63 - 2.49) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.03 (1.65 - 2.52) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.53 (1.23 - 1.91) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.85 (0.66 - 1.13) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 11.9 (10.64 - 34.63) | 2007 | Modelled | Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan |
| 1.6 (0.56 - 2.65) | 2013 | Modelled | Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan |
| 1.5 (0.64 - 2.42) | 2014 | Modelled | Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan |
| 3.5 | 2016 | Survey/reported | Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 393,493 (320,660 - 489,118) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 405,212 (329,215 - 503,117) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 415,989 (336,847 - 516,111) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 425,549 (345,167 - 527,899) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 433,727 (350,916 - 541,116) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 440,535 (354,894 - 550,545) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 448,467 (361,661 - 560,925) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 456,687 (369,921 - 569,706) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 463,906 (375,375 - 578,708) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 470,859 (381,836 - 586,626) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 477,453 (386,362 - 593,254) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 483,094 (390,772 - 602,405) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 487,586 (393,262 - 604,361) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 492,585 (398,109 - 610,008) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 498,859 (403,268 - 618,854) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 505,615 (408,717 - 628,372) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 512,795 (414,412 - 637,074) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 520,342 (420,313 - 647,115) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 527,721 (425,329 - 656,847) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 533,766 (428,246 - 665,877) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 538,741 (430,711 - 675,059) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 543,654 (435,216 - 680,372) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 548,715 (439,948 - 687,765) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 554,603 (444,759 - 691,488) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 561,861 (451,332 - 698,771) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 572,377 (459,919 - 713,926) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 587,605 (472,779 - 731,879) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 602,861 (483,725 - 755,317) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 615,469 (496,304 - 768,446) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 627,614 (506,265 - 786,175) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 622,716 (501,864 - 780,012) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 88,800 (68,300 - 118,000) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 4.49 (2.80 - 7.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 5.69 (3.71 - 7.90) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.64 (3.72 - 7.93) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.53 (3.68 - 7.90) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.59 (3.69 - 7.91) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.49 (3.67 - 7.89) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.45 (3.58 - 7.97) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.32 (3.46 - 7.81) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.39 (3.55 - 7.87) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.23 (3.41 - 7.79) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.15 (3.28 - 7.83) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.06 (3.18 - 7.84) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.98 (3.10 - 7.77) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.94 (3.06 - 7.72) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.8 (2.95 - 7.46) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.87 (3.02 - 7.56) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.66 (2.81 - 7.25) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.73 (2.88 - 7.33) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.58 (2.77 - 7.21) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.51 (2.72 - 7.19) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.43 (2.66 - 7.03) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.46 (2.70 - 7.08) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.39 (2.66 - 6.97) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.39 (2.67 - 6.95) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.41 (2.68 - 6.95) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.43 (2.68 - 6.95) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.42 (2.70 - 6.98) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.51 (2.74 - 7.18) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.45 (2.71 - 7.01) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.49 (2.77 - 7.06) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 4.49 (2.80 - 7.03) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,548 | 2016 | Modelled | WHO |
| 1,832 (1,144 - 2,867) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,832 (1,144 - 2,867) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1,799 (1,110 - 2,831) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,773 (1,076 - 2,822) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,708 (1,040 - 2,693) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,653 (1,008 - 2,606) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,616 (979 - 2,535) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,574 (956 - 2,480) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,534 (933 - 2,429) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,505 (910 - 2,388) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,489 (894 - 2,365) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,476 (893 - 2,342) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,462 (882 - 2,331) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,449 (875 - 2,281) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,437 (866 - 2,238) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,426 (868 - 2,210) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,412 (868 - 2,196) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,403 (870 - 2,178) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,398 (866 - 2,184) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,386 (862 - 2,161) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,380 (867 - 2,135) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,370 (873 - 2,082) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,357 (883 - 2,020) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,342 (872 - 1,971) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,321 (869 - 1,928) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,299 (854 - 1,899) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,276 (854 - 1,833) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,248 (831 - 1,783) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,220 (806 - 1,728) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,187 (783 - 1,670) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,149 (749 - 1,597) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
Hepatitis related deaths (national)
Modelled
HBV
1,746
2019
(990 - 3,014)
IHME, GBD 2019 (accessed 2020)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
1,832
2019
(1,144 - 2,867)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines
